Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8363 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.8306 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.8306 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.8118 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD6454 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD2511 |
Approved |
0.8057 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD482 |
Approved |
0.7989 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7989 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.7989 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7979 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD7666 |
Phase 3 |
0.7958 |
Intermediate Similarity |
NPD7665 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.7946 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD751 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7892 |
Intermediate Similarity |
NPD4703 |
Approved |
0.7889 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.7889 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD7001 |
Phase 3 |
0.784 |
Intermediate Similarity |
NPD2896 |
Discontinued |
0.7819 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.7796 |
Intermediate Similarity |
NPD4602 |
Approved |
0.7784 |
Intermediate Similarity |
NPD5505 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD201 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD200 |
Phase 2 |
0.776 |
Intermediate Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD2336 |
Approved |
0.7714 |
Intermediate Similarity |
NPD4174 |
Clinical (unspecified phase) |
0.7713 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6665 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD4852 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD4383 |
Clinical (unspecified phase) |
0.7579 |
Intermediate Similarity |
NPD4397 |
Phase 1 |
0.7566 |
Intermediate Similarity |
NPD2307 |
Discontinued |
0.7563 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD5555 |
Phase 1 |
0.7552 |
Intermediate Similarity |
NPD5017 |
Discontinued |
0.7539 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD6965 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD3475 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3476 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7513 |
Intermediate Similarity |
NPD5975 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4736 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5065 |
Approved |
0.75 |
Intermediate Similarity |
NPD5322 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD4638 |
Approved |
0.7472 |
Intermediate Similarity |
NPD4640 |
Approved |
0.7472 |
Intermediate Similarity |
NPD4639 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4547 |
Phase 3 |
0.7459 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD5100 |
Phase 3 |
0.7443 |
Intermediate Similarity |
NPD5400 |
Approved |
0.7442 |
Intermediate Similarity |
NPD5965 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD2119 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2118 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7712 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD2012 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7378 |
Intermediate Similarity |
NPD3385 |
Approved |
0.7374 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7371 |
Intermediate Similarity |
NPD4326 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD1661 |
Suspended |
0.7366 |
Intermediate Similarity |
NPD4336 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD1568 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD5257 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD2809 |
Approved |
0.7354 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD3947 |
Discontinued |
0.734 |
Intermediate Similarity |
NPD7234 |
Approved |
0.734 |
Intermediate Similarity |
NPD7233 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD4427 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD5255 |
Approved |
0.7326 |
Intermediate Similarity |
NPD5809 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD4600 |
Approved |
0.732 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7317 |
Intermediate Similarity |
NPD1627 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7304 |
Intermediate Similarity |
NPD7168 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD3583 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD4988 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD4520 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5862 |
Discovery |
0.7278 |
Intermediate Similarity |
NPD1722 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4028 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4030 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4029 |
Approved |
0.7264 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD4345 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7245 |
Intermediate Similarity |
NPD7187 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD5897 |
Approved |
0.7243 |
Intermediate Similarity |
NPD5898 |
Approved |
0.7243 |
Intermediate Similarity |
NPD5899 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3654 |
Approved |
0.7236 |
Intermediate Similarity |
NPD2916 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD2006 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD7026 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7228 |
Intermediate Similarity |
NPD2144 |
Approved |
0.7228 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD6165 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD2430 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD6164 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD5611 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD6281 |
Approved |
0.7209 |
Intermediate Similarity |
NPD6148 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD1631 |
Approved |
0.7206 |
Intermediate Similarity |
NPD6710 |
Phase 3 |
0.7206 |
Intermediate Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD4011 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD4848 |
Phase 1 |
0.7196 |
Intermediate Similarity |
NPD4948 |
Discontinued |
0.7196 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD8431 |
Approved |
0.7193 |
Intermediate Similarity |
NPD3813 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD7970 |
Approved |
0.7189 |
Intermediate Similarity |
NPD8037 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD8036 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD1292 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD2390 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD4805 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5020 |
Approved |
0.7174 |
Intermediate Similarity |
NPD5471 |
Phase 3 |
0.7173 |
Intermediate Similarity |
NPD5592 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD6323 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD3944 |
Approved |
0.7169 |
Intermediate Similarity |
NPD3942 |
Approved |
0.7167 |
Intermediate Similarity |
NPD2720 |
Phase 1 |
0.7167 |
Intermediate Similarity |
NPD2719 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD6204 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD786 |
Approved |
0.7158 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD4334 |
Discontinued |
0.7156 |
Intermediate Similarity |
NPD7824 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6452 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD4384 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2882 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5820 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD484 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2305 |
Discontinued |
0.7136 |
Intermediate Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD3430 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8123 |
Approved |
0.7135 |
Intermediate Similarity |
NPD2753 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD8122 |
Approved |
0.7135 |
Intermediate Similarity |
NPD3431 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7204 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD4987 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD5636 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD3321 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD5088 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD7469 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD4076 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4079 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7088 |
Intermediate Similarity |
NPD4779 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.7083 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6044 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD6471 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD3238 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD2581 |
Approved |
0.7079
|
Intermediate Similarity |
NPD2582 |
Approved |